Ottawa, ON & Partnerships with CROs Conference, Las Vegas, NV (PRWEB) April 4, 2006
TrialStat Corporation today presented its ClinicalAnalytics 3.0 (CA3) disconnected electronic data capture (EDC) technology at the 15th Annual Partnerships with CROs event in Las Vegas, Nevada. CA3, the most advanced integrated EDC platform available to the clinical research market, allows web-based data capture forms to be seamlessly deployed to a variety of platforms including Palms, PocketPCs and tablet PCs for wireless and disconnected use without the need for programming or customization.
With single click deployment of forms to a wide variety of portable devices, researchers now have the freedom to choose devices and platforms that best suit their study environment. With CA3, study forms exhibit exactly the same appearance and behavior whether viewed though the secure web portal or on a disconnected handheld device.
"Finally, a clinical study platform that investigators can actually use. TrialStat's technology is self configurable; the content and control rests in the user's hands. It's scaleable and applicable to tiny or massive projects, without prohibitive cost,” said Dr. David G. Barnes, Product Development and Regulatory Advisor, PharmaGap. “Moreover, the project oversight features are wonderful. Everything from patient recruitment to aspects of study compliance can be monitored in real time; this will be a huge cost-saving and risk-mitigating benefit to companies running trials.”
ClinicalAnalytics 3.0 has achieved a number of industry firsts including complete study configurability through a browser interface and seamless integration of handheld and disconnected devices. Both features empower the research team while reducing the time and expense associated with deploying EDC on studies. CA3 is offered as a web-based service thus providing access to a fully compliant, industrial grade platform without having to invest substantially in IT.
“There are many circumstances that require data to be collected in locations where no network is available or where wireless access is not permitted,” said Jonathan Barker, president, TrialStat. “With ClinicalAnalytics 3.0, researchers have the freedom to securely capture data at the source and enter it directly into their secure electronic forms without having to rely on a live Internet connection.”
TrialStat’s ClinicalAnalytics 3.0 with integrated support for disconnected devices is now generally available and is already in use in clinical studies in North America and Europe.
TrialStat is a privately-held information technology firm with products and services that go beyond traditional EDC solutions to address the complete data management picture. From the industry’s most advanced integrated EDC platform to biostatistical support, adverse event coding, study monitoring and project management, TrialStat delivers flexible, proven data management on demand. For more information, please visit http://www.trialstat.com.
For media and analyst inquiries only, contact:
Media Relations, TrialStat
Media Relations, TrialStat
# # #